The burden of fungal disease in Denmark

Mycoses

Volumn 58, Issue , 2015, Pages 15-21

  Mortensen, Klaus L ^a   Denning, David W ^b   Arendrup, Maiken C ^c  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c STATENS SERUM INSTITUT   (Denmark)

Author keywords

Aspergillosis; Candidiasis; Denmark; Fungal; Global; HIV

Indexed keywords

ADOLESCENT; ADULT; ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; ASTHMA; CANDIDEMIA; CHILD; CRYPTOCOCCAL MENINGITIS; DENMARK; DERMATOMYCOSIS; DERMATOPHYTE; DIMORPHIC FUNGAL INFECTION; DISABILITY; EPIDEMIOLOGICAL DATA; ESOPHAGUS CANDIDIASIS; FEMALE; HEMATOLOGIC DISEASE; HIGH RISK POPULATION; HUMAN; INCIDENCE; INFECTION RISK; INVASIVE ASPERGILLOSIS; INVASIVE CANDIDIASIS; KERATOMYCOSIS; LUNG ASPERGILLOSIS; MAJOR CLINICAL STUDY; MALE; MUCORMYCOSIS; MYCOSIS; ONYCHOMYCOSIS; ORGAN TRANSPLANTATION; PERITONITIS; PNEUMOCYSTIS PNEUMONIA; POPULATION; PREVALENCE; PRIORITY JOURNAL; SENSITIZATION; SEVERE ASTHMA WITH FUNGAL SENSITIZATION; THRUSH; TINEA CAPITIS; VAGINA CANDIDIASIS; VOLUNTARY REPORTING; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ASPERGILLOSIS; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; COST OF ILLNESS; EUROPE; MICROBIOLOGY; MIDDLE AGED; MYCOSES; PULMONARY ASPERGILLOSIS; YOUNG ADULT;

ADOLESCENT; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ASPERGILLOSIS; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; ASTHMA; CANDIDEMIA; COST OF ILLNESS; DENMARK; EUROPE; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; MYCOSES; PREVALENCE; PULMONARY ASPERGILLOSIS; YOUNG ADULT;

EID: 84943389858     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/myc.12383     Document Type: Article

References (37)

1. Arendrup MC, Fuursted K, Gahrn-Hansen B et al. Seminational surveillance of fungemia in Denmark: notably high rates of fungemia and numbers of isolates with reduced azole susceptibility. J Clin Microbiol 2005; 43: 4434-40.
2. Arendrup MC, Dzajic E, Jensen RH et al. Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme. Clin Microbiol Infect 2013; 19: E343-53.
3. Vos T, Flaxman AD, Naghavi M et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2163-96.
4. Denning DW, Pleuvry A, Cole DC. Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis. Bull World Health Organ 2011; 89: 864.
5. Denning DW, Pleuvry A, Cole DC. Global burden of chronic pulmonary aspergillosis complicating sarcoidosis. Eur Respir J 2013; 41: 621-6.
6. Denning DW, Pleuvry A, Cole DC. Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults. Med Mycol 2013; 51: 361-70.
7. Oladele RO, Denning DW. Burden of serious fungal infection in Nigeria. West Afr J Med 2014; 33: 107-14.
8. Rodriguez-Tudela J, Alastruey-Izquirdo A, Gago S et al. Burden of serious fungal infections in Spain. Clin Microbiol Infect 2014; 21: 183-9.
9. Saunte DM, Svejgaard EL, Haedersdal M, Frimodt-Møller N, Jensen AM, Arendrup MC. Laboratory-based survey of dermatophyte infections in Denmark over a 10-year period. Acta Derm Venereol 2008; 88: 614-16.
10. Nielsen SE, Nielsen E, Julian HO et al. Incidence and clinical characteristics of fungal keratitis in a Danish population from 2000 to 2013. Acta Ophthalmol 2015; 93: 54-8.
11. Foxman B, Muraglia R, Dietz J-P, Sobel JD, Wagner J. Prevalence of recurrent vulvovaginal candidiasis in 5 European countries and the United States: results from an internet panel survey. J Low Genit Tract Dis 2013; 17: 340-5.
12. Omland LH, Ahlström MG, Obel N. Cohort profile update: the Danish HIV Cohort Study (DHCS). Int J Epidemiol 2014; 43: 1769-9e.
13. Helleberg M, Häggblom A, Sönnerborg A, Obel N. HIV care in the Swedish-Danish HIV Cohort 1995-2010. Closing the Gaps. PLoS ONE 2013; 8: e72257.
14. Smith NL, Denning DW. Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma. Eur Respir J 2011; 37: 865-72.
15. Von Bülow A, Backer V, Porsbjerg C. Severe asthma - where are we today? Ugeskr Laeger 2014; 13: 176.
16. Denning DW, O'Driscoll BR, Hogaboam CM, Bowyer P, Niven RM. The link between fungi and severe asthma: a summary of the evidence. Eur Respir J 2006; 27: 615-26.
17. Armstead J, Morris J, Denning DW. Multi-country estimate of different manifestations of aspergillosis in cystic fibrosis. PLoS ONE 2014; 9: e98502.
18. Engholm G, Ferlay J, Christensen N et al. NORDCAN: Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries, Version 6.1. Assoc. Nord. Cancer Regist. Danish Cancer Soc [WWW document]. URL http// www.ancr.nu [accessed on 25 April 2014].
19. Engholm G, Ferlay J, Christensen N et al. NORDCAN-a Nordic tool for cancer information, planning, quality control and research. Acta Oncol 2010; 49: 725-36.
20. Pagano L, Caira M, Candoni A et al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica 2006; 91: 1068-75.
21. Guinea J, Torres-Narbona M, Gijón P et al. Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome. Clin Microbiol Infect 2010; 16: 870-7.
22. Clancy CJ, Nguyen MH. Finding the "missing 50%" of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care. Clin Infect Dis 2013; 56: 1284-92.
23. Herbrecht R, Bories P, Moulin J-C, Ledoux M-P, Letscher-Bru V. Risk stratification for invasive aspergillosis in immunocompromised patients. Ann N Y Acad Sci 2012; 1272: 23-30.
24. Iversen M, Burton CM, Vand S et al. Aspergillus infection in lung transplant patients: incidence and prognosis. Eur J Clin Microbiol Infect Dis 2007; 26: 879-86.
25. López-Campos Bodineau JL, Fernández Guerra J, Lara Blanquer A et al. Analysis of admissions for chronic obstructive pulmonary disease in Andalusia in 2000. Arch Bronconeumol 2002; 38: 473-8.
26. Thorsteinsson K, Ladelund S, Jensen-Fangel S et al. Impact of gender on the risk of AIDS-defining illnesses and mortality in Danish HIV-1-infected patients: a nationwide cohort study. Scand J Infect Dis 2012; 44: 766-75.
27. Puig-Asensio M, Padilla B, Garnacho-Montero J et al. Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain. Clin Microbiol Infect 2014; 20: O245-54.
28. Cleveland AA, Farley MM, Harrison LH et al. Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008-2011. Clin Infect Dis 2012; 55: 1352-61.
29. Arendrup MC, Sulim S, Holm A et al. Diagnostic issues, clinical characteristics, and outcomes for patients with fungemia. J Clin Microbiol 2011; 49: 3300-8.
30. Montravers P, Mira J-P, Gangneux J-P, Leroy O, Lortholary O. A multicentre study of antifungal strategies and outcome of Candida spp. peritonitis in intensive-care units. Clin Microbiol Infect 2011; 17: 1061-7.
31. Mathiesen IHM, Knudsen JD, Gerstoft J, Cowan S, Benfield T. Outcome of HIV-1-associated cryptococcal meningitis, Denmark 1988-2008. Scand J Infect Dis 2012; 44: 197-200.
32. Torres-Narbona M, Guinea J, Martínez-Alarcón J, Muñoz P, Gadea I, Bouza E. Impact of zygomycosis on microbiology workload: a survey study in Spain. J Clin Microbiol 2007; 45: 2051-3.
33. Wilson LS, Reyes CM, Stolpman M, Speckman J, Allen K, Beney J. The direct cost and incidence of systemic fungal infections. Value Health 2002; 5: 26-34.
34. Hope WW, Walsh TJ, Denning DW. The invasive and saprophytic syndromes due to Aspergillus spp. Med Mycol 2005; 43(Suppl 1): S207-38.
35. Mortensen KL, Johansen HK, Fuursted K et al. A prospective survey of Aspergillus spp. in respiratory tract samples: prevalence, clinical impact and antifungal susceptibility. Eur J Clin Microbiol Infect Dis 2011; 30: 1355-63.
36. Brown GD, Denning DW, Gow NAR, Levitz SM, Netea MG, White TC. Hidden killers: human fungal infections. Sci Transl Med 2012; 4: 165rv13.
37. Murray CJL, Ortblad KF, Guinovart C et al. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014; 384: 1005-70.